CN108567906B - 一种紫草膏及其制备方法 - Google Patents
一种紫草膏及其制备方法 Download PDFInfo
- Publication number
- CN108567906B CN108567906B CN201810696990.5A CN201810696990A CN108567906B CN 108567906 B CN108567906 B CN 108567906B CN 201810696990 A CN201810696990 A CN 201810696990A CN 108567906 B CN108567906 B CN 108567906B
- Authority
- CN
- China
- Prior art keywords
- parts
- lithospermum
- radix
- beeswax
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001071917 Lithospermum Species 0.000 title claims abstract description 56
- 239000002674 ointment Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000013871 bee wax Nutrition 0.000 claims abstract description 30
- 239000012166 beeswax Substances 0.000 claims abstract description 30
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 21
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 15
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 15
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 15
- 241000219784 Sophora Species 0.000 claims abstract description 15
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940116229 borneol Drugs 0.000 claims abstract description 14
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000004006 olive oil Substances 0.000 claims abstract description 14
- 235000008390 olive oil Nutrition 0.000 claims abstract description 14
- 238000001816 cooling Methods 0.000 claims abstract description 13
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 35
- 239000000706 filtrate Substances 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 11
- 241000382455 Angelica sinensis Species 0.000 claims description 10
- 241001180876 Saposhnikovia Species 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 229940023462 paste product Drugs 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 3
- 240000002299 Symphytum officinale Species 0.000 claims 1
- 235000005865 Symphytum officinale Nutrition 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 201000004624 Dermatitis Diseases 0.000 abstract description 13
- 208000010668 atopic eczema Diseases 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 12
- 208000025865 Ulcer Diseases 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 231100000397 ulcer Toxicity 0.000 abstract description 9
- 208000003251 Pruritus Diseases 0.000 abstract description 8
- 241001448624 Miliaria Species 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 206010053615 Thermal burn Diseases 0.000 abstract description 5
- 208000014617 hemorrhoid Diseases 0.000 abstract description 5
- 206010002153 Anal fissure Diseases 0.000 abstract description 4
- 208000016583 Anus disease Diseases 0.000 abstract description 4
- 206010003399 Arthropod bite Diseases 0.000 abstract description 4
- 208000009531 Fissure in Ano Diseases 0.000 abstract description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 4
- 208000024780 Urticaria Diseases 0.000 abstract description 4
- 208000007287 cheilitis Diseases 0.000 abstract description 4
- 210000002850 nasal mucosa Anatomy 0.000 abstract description 4
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 3
- 208000035874 Excoriation Diseases 0.000 abstract description 3
- 206010000496 acne Diseases 0.000 abstract description 3
- 210000001217 buttock Anatomy 0.000 abstract description 3
- 238000005469 granulation Methods 0.000 abstract description 3
- 230000003179 granulation Effects 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 2
- 201000004647 tinea pedis Diseases 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 208000002399 aphthous stomatitis Diseases 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 8
- 206010037844 rash Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 241000125175 Angelica Species 0.000 description 3
- 241001313855 Bletilla Species 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 2
- 241001313857 Bletilla striata Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000118825 Alkanna tinctoria Species 0.000 description 1
- 241000130781 Arnebia Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- NEZONWMXZKDMKF-UHFFFAOYSA-N C.I. Natural Red 20 Chemical compound C1=CC(O)=C2C(=O)C(C(O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010014198 Eczema infantile Diseases 0.000 description 1
- 206010049307 Lip blister Diseases 0.000 description 1
- 240000004035 Lithospermum officinale Species 0.000 description 1
- 235000011030 Lithospermum officinale Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- MXANJRGHSFELEJ-MRXNPFEDSA-N [(1r)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 3-hydroxy-3-methylbutanoate Chemical compound C1=CC(O)=C2C(=O)C([C@H](OC(=O)CC(C)(C)O)CC=C(C)C)=CC(=O)C2=C1O MXANJRGHSFELEJ-MRXNPFEDSA-N 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MXANJRGHSFELEJ-UHFFFAOYSA-N beta:-hydroxy isovaleryl shikonin Natural products C1=CC(O)=C2C(=O)C(C(OC(=O)CC(C)(C)O)CC=C(C)C)=CC(=O)C2=C1O MXANJRGHSFELEJ-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种紫草膏及其制备方法,涉及中草药技术领域。本发明的紫草膏包括以下重量份的原材料:紫草80‑120份,白芷40‑60份,当归40‑60份,生地黄40‑60份,金银花40‑60份,防风40‑60份,白及40‑60份,丹参40‑60份,生槐花40‑60份,冰片20‑40份,食用橄榄油900‑950份,蜂蜡180‑230份。本发明的紫草膏使用时直接涂抹于患处皮肤,具有清热解毒、凉血化瘀和敛疮生肌的功效;可用于轻度烫伤、蚊虫叮咬、宝宝红屁股、湿疹脚气、皮肤擦伤、唇炎、痱子、青春痘、荨麻疹、鼻黏膜溃烂、口唇水泡、痔疮肛裂及外阴瘙痒及溃疡等。
Description
技术领域
本发明涉及中草药技术领域,尤其涉及一种紫草膏及其制备方法。
背景技术
紫草又名山紫草、紫丹、紫草根,多年生草本,是中草药的一种,春秋春秋挖根,除去残茎及泥土,晒干或微火烘干,生用。紫草的化学成分包含乙酰紫草素(acetylshikonin)、β-羟基异戊酰紫草素(β-hydro-xyisovalerylshikonin)、紫草素(shikonin)、β,β’-二甲基丙烯酰紫草素(β,β'-dimethylacrylshikonin)等。紫草作为一种中医药材,性味苦寒,具有凉血,活血,解毒透疹功效,可用于血热毒盛、斑疹紫黑、麻疹不透、疮疡、湿疹、水火烫伤。紫草在美容领域可加速痘印和疤痕的新陈代谢,具有良好的杀菌消炎作用。
紫草常与其他药物成分混合熬成膏状用于外涂。例如常见的幼儿湿疹或红屁股,但由于其药物配方和/或制备方法设计不合理或具有一定副作用或疗效较差;因此,还需在前人研究基础上充分提高紫草膏的药用价值和疗效。
发明内容
有鉴于此,本发明实施例提供了一种紫草膏及其制备方法,主要目的是提高紫草用于治疗皮肤损伤的效果和应用范围。
为达到上述目的,本发明主要提供了如下技术方案:
一方面,本发明实施例提供了一种紫草膏,所述紫草膏包括以下重量份的原材料:
紫草80-120份,白芷40-60份,当归40-60份,生地黄40-60份,金银花40-60份,防风40-60份,白及40-60份,丹参40-60份,生槐花40-60份,冰片20-40份,食用橄榄油900-950份,蜂蜡180-230份。
作为优选,所述紫草膏包括以下重量份的原材料:紫草90-110份,白芷45-55份,当归45-55份,生地黄45-55份,金银花45-55份,防风45-55份,白及45-55份,丹参45-55份,生槐花45-55份,冰片25-35份,食用橄榄油900-920份,蜂蜡190-210份。
作为优选,所述紫草膏包括以下重量份的原材料:紫草100份,白芷50份,当归50份,生地黄50份,金银花50份,防风50份,白及50份,丹参50份,生槐花50份,冰片30份,食用橄榄油905-915份,蜂蜡200份。
另一方面,本发明实施例提供了上述紫草膏的制备方法,所述方法包括以下步骤:
按配方准备各原材料;
将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片直接用食用橄榄油浸泡5-6个月或将原材料先制成粉末后再浸泡10日,得到第一混合物;
对所述第一混合物进行过滤,留取滤液;
向所述滤液中加入蜂蜡,形成第二混合物;
对所述第二混合物隔水加热至所述蜂蜡完全溶化;
溶化后的所述第二混合物经冷却后成固体膏状物,即紫草膏产品。
本发明配方中的紫草性味苦寒,具有凉血,活血,解毒透疹功效,可用于血热毒盛、斑疹紫黑、麻疹不透、疮疡、湿疹、水火烫伤。
本发明配方中的白芷,解表散寒,祛风止痛,通鼻窍,燥湿止带,消肿排脓;
本发明配方中的当归,补血活血,调经止痛,润肠通便;
本发明配方中的生地黄,清热凉血,养阴生津;
本发明配方中的金银花,清热解毒,疏散风热;
本发明配方中的防风,祛风解表,胜湿止痛,解痉止痒;
本发明配方中的白及,收敛止血,消肿生肌;
本发明配方中的丹参,活血通经,宁心安神,排脓止痛;
本发明配方中的生槐花,清热泻火,凉血止血;
本发明配方中的冰片,开窍醒神,清热止痛。
本发明配方中的食用橄榄油含有饱和脂肪酸,棕榈油酸、油酸、亚油酸和亚麻酸等。
与现有技术相比,本发明的有益效果是:
本发明通过合理设计紫草膏配方以及改进其制备方法,将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片直接用食用橄榄油浸泡5-6个月或将原材料先制成粉末后再浸泡10日,经过滤取滤液,再加入蜂蜡,隔水加热至其溶化后再冷却即得紫草膏产品;采用本发明配方和方法制备的紫草膏使用时直接涂抹于患处皮肤;本发明的紫草膏具有清热解毒、凉血化瘀和敛疮生肌的功效;可用于轻度烫伤、蚊虫叮咬、宝宝红屁股、湿疹脚气、皮肤擦伤、唇炎、痱子、青春痘、荨麻疹、鼻黏膜溃烂、口唇水泡、痔疮肛裂及外阴瘙痒及溃疡等,还可令唇部肌肤娇嫩,促进角质层代谢,并可用于顽固湿疹、牛皮癣或褥疮的辅助治疗。
具体实施方式
为更进一步阐述本发明为达成预定发明目的所采取的技术手段及功效,以下以较佳实施例,对依据本发明申请的具体实施方式、技术方案、特征及其功效,详细说明如后。下述说明中的多个实施例中的特定特征、结构、或特点可由任何合适形式组合。
实施例1
按以下配方准备各药材:紫草80g,白芷40g,当归40g,生地黄40g,金银花40g,防风40g,白及40g,丹参40g,生槐花40g,冰片20g,食用橄榄油1000mL(相对密度为0.909-0.915g/cm3),蜂蜡180g;
将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片直接用食用橄榄油浸泡5-6个月,得到第一混合物;对上述第一混合物进行过滤,留取滤液;向上述滤液中加入蜂蜡,形成第二混合物;对上述第二混合物隔水加热至上述蜂蜡完全溶化;溶化后的上述第二混合物经冷却后成固体膏状物,即紫草膏产品,颜色为紫红色,膏状固体。
实施例2
按以下配方准备各药材:紫草90g,白芷45g,当归45g,生地黄45g,金银花45g,防风45g,白及45g,丹参45g,生槐花45g,冰片25g,食用橄榄油1000mL(相对密度为0.909-0.915g/cm3),蜂蜡190g;
将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片先制成粉末后再用橄榄油浸泡10日,得到第一混合物;对上述第一混合物进行过滤,留取滤液;向上述滤液中加入蜂蜡,形成第二混合物;对上述第二混合物隔水加热至上述蜂蜡完全溶化;溶化后的上述第二混合物经冷却后成固体膏状物,即紫草膏产品,颜色为紫红色,膏状固体。
实施例3
按以下配方准备各药材:紫草100g,白芷50g,当归50g,生地黄50g,金银花50g,防风50g,白及50g,丹参50g,生槐花50g,冰片30g,食用橄榄油1000mL(相对密度为0.909-0.915g/cm3),蜂蜡200g;
将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片先制成粉末后再用橄榄油浸泡10日,得到第一混合物;对上述第一混合物进行过滤,留取滤液;向上述滤液中加入蜂蜡,形成第二混合物;对上述第二混合物隔水加热至上述蜂蜡完全溶化;溶化后的上述第二混合物经冷却后成固体膏状物,即紫草膏产品,颜色为紫红色,膏状固体。
实施例4
按以下配方准备各药材:紫草110g,白芷55g,当归55g,生地黄55g,金银花55g,防风55g,白及55g,丹参55g,生槐花55g,冰片35g,食用橄榄油1000mL(相对密度为0.909-0.915g/cm3),蜂蜡210g;
将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片先制成粉末后再用橄榄油浸泡10日,得到第一混合物;对上述第一混合物进行过滤,留取滤液;向上述滤液中加入蜂蜡,形成第二混合物;对上述第二混合物隔水加热至上述蜂蜡完全溶化;溶化后的上述第二混合物经冷却后成固体膏状物,即紫草膏产品,颜色为紫红色,膏状固体。
实施例5
按以下配方准备各药材:紫草120g,白芷60g,当归60g,生地黄60g,金银花60g,防风60g,白及60g,丹参60g,生槐花60g,冰片40g,食用橄榄油1000mL(相对密度为0.909-0.915g/cm3),蜂蜡220g;
将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片先制成粉末后再用橄榄油浸泡10日,得到第一混合物;对上述第一混合物进行过滤,留取滤液;向上述滤液中加入蜂蜡,形成第二混合物;对上述第二混合物隔水加热至上述蜂蜡完全溶化;溶化后的上述第二混合物经冷却后成固体膏状物,即紫草膏产品,颜色为紫红色,膏状固体。
通过本发明上述实施例1-实施例5制备得到5种不同配方的紫草膏,经过临床试验,本发明实施例3的配方及方法制备的紫草膏效果最好。
本发明对前人传统配方进行了改进,独特之处在于,增加了4味中药,扩大了治疗范围:选用了可收敛止血、消肿生肌的白芨,其可治疗皮肤溃烂;选用了可清热泻火、凉血止血的生槐花,其可治疗痔疮、肛裂;选用了活血通经、排脓止痛的丹参,其加强疗效;选用了清热解毒,疏散风热的金银花,其加强了清热解毒的功效。
本发明紫草膏病例资料:2010-2017年累计治疗620例患者;其中,281例患者为婴幼儿,病状为宝宝红屁股、蚊虫叮咬、湿疹、痱子、荨麻疹或者多症状出现,113例青少年或成年的湿疹脚气,68例青春痘,58例唇炎,46例痔疮,37例鼻黏膜溃烂,17例牛皮癣;上述620例患者使用紫草膏后,大部分病情均得到治愈,有效治愈率达到94.9%左右,5.1%因个体差异无效。
本发明紫草膏的使用方法为外涂于患处皮肤。
本发明的临床疗效评定标准:
完全缓解:皮肤和正常无差别。
显效:皮肤泛红、瘙痒或疼痛消失,溃疡愈合。
有效:皮肤泛红、瘙痒或疼痛减轻,溃疡部分愈合或伤口变浅。
无效:皮肤泛红、瘙痒或疼痛未见改善,溃疡未愈合。
总有效率=(临床缓解+显效+有效)/接受该疗法的所有病例数。
应用例1
王某,男性,5个月,患有红屁股和湿疹,臀部皮肤泛红,周身红疹,涂抹本发明实施例3的紫草膏3天后,症状消除,2周内未犯。
应用例2
商某,女性,55岁,患有干性湿疹,下肢和颈部瘙痒难忍,1天后症状消除,2次痊愈。
应用例3
牛某,男性,进食四川火锅后,唇部皮肤干裂疼痛,涂抹曼秀雷敦润唇膏1周,未见缓解,涂抹本发明实施例3的紫草膏1天后,唇部皮肤愈合,2月内未犯。
应用例4
修某,女,43岁,患有神经性皮炎,面部皮肤泛红,瘙痒,刺痛,脱皮,涂抹本发明实施例3的紫草膏1天后,症状消除,1月内未犯。
应用例5
毕某,男性,8岁,感冒后,擦鼻涕导致鼻部皮肤破溃,涂抹本发明实施例3的紫草膏1天后,肌肤愈合,5个月未犯。
应用例6
张某,男性,3个月,后背遍布痱子,涂抹本发明实施例3的紫草膏1天后,疹退,皮肤光滑,3月未犯。
应用例7
杨某,女性,35岁,外阴瘙痒,肛门湿疹,涂抹本发明实施例3的紫草膏1天后,瘙痒及湿疹减轻,1周后,皮肤恢复如常,2个月未犯。
本发明人根据多年临床经验,就轻度烫伤、蚊虫叮咬、宝宝红屁股、湿疹脚气、皮肤擦伤、唇炎、痱子、青春痘、荨麻疹、鼻黏膜溃烂、口唇水泡、痔疮肛裂及外阴瘙痒及溃疡等症状做过仔细研究,多为皮肤过敏所致,内有湿热,郁于皮肤而发,发现将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片等按照本发明方法制备成紫草膏治疗时效果很好,本发明人在前人制备方法及配方上做了调整和改进,研制的紫草膏疗效甚好。
本发明通过对620例患者病情进行观察分析,涂抹本发明的紫草膏疗效相比普通市面上常见的紫草膏效果较好,治愈率高,治疗的病状种类较多,且无副作用,可临床推广使用。本发明所用中药均为口服中药、食用蜂蜡、食用橄榄油,安全可靠。
本发明实施例中未尽之处,本领域技术人员均可从现有技术中选用。
以上公开的仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以上述权利要求的保护范围为准。
Claims (3)
1.一种紫草膏,其特征在于,所述紫草膏由以下重量份的原材料组成:
紫草90-110份,白芷45-55份,当归45-55份,生地黄45-55份,金银花45-55份,防风45-55份,白及45-55份,丹参45-55份,生槐花45-55份,冰片25-35份,食用橄榄油900-920份,蜂蜡190-210份。
2.如权利要求1所述一种紫草膏,其特征在于,所述紫草膏包括以下重量份的原材料:紫草100份,白芷50份,当归50份,生地黄50份,金银花50份,防风50份,白及50份,丹参50份,生槐花50份,冰片30份,食用橄榄油905-915份,蜂蜡200份。
3.权利要求1-2任一项所述的一种紫草膏的制备方法,其特征在于,所述方法包括以下步骤:
按配方准备各原材料;
将紫草、白芷、当归、生地黄、金银花、防风、白及、丹参、生槐花及冰片直接用食用橄榄油浸泡5-6个月或将原材料先制成粉末后再浸泡10日,得到第一混合物;
对所述第一混合物进行过滤,留取滤液;
向所述滤液中加入蜂蜡,形成第二混合物;
对所述第二混合物隔水加热至所述蜂蜡完全溶化;
溶化后的所述第二混合物经冷却后成固体膏状物,即紫草膏产品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810696990.5A CN108567906B (zh) | 2018-06-29 | 2018-06-29 | 一种紫草膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810696990.5A CN108567906B (zh) | 2018-06-29 | 2018-06-29 | 一种紫草膏及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108567906A CN108567906A (zh) | 2018-09-25 |
CN108567906B true CN108567906B (zh) | 2021-05-07 |
Family
ID=63573743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810696990.5A Active CN108567906B (zh) | 2018-06-29 | 2018-06-29 | 一种紫草膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108567906B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114306410B (zh) * | 2022-01-14 | 2023-09-19 | 建昌帮药业有限公司 | 一种紫草膏及其制备方法与应用 |
CN115844989A (zh) * | 2022-12-06 | 2023-03-28 | 东莞市中医院 | 一种治疗银屑病红皮病型的中药外用膏剂及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101219190A (zh) * | 2007-01-09 | 2008-07-16 | 李保力 | 一种治疗烧烫伤的中药制剂及药膏 |
CN103599181A (zh) * | 2013-11-29 | 2014-02-26 | 苏国仁 | 一种治疗痤疮的药物 |
CN106138723A (zh) * | 2016-07-26 | 2016-11-23 | 合肥宝花堂健康咨询有限公司 | 一种外用中药膏 |
-
2018
- 2018-06-29 CN CN201810696990.5A patent/CN108567906B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101219190A (zh) * | 2007-01-09 | 2008-07-16 | 李保力 | 一种治疗烧烫伤的中药制剂及药膏 |
CN103599181A (zh) * | 2013-11-29 | 2014-02-26 | 苏国仁 | 一种治疗痤疮的药物 |
CN106138723A (zh) * | 2016-07-26 | 2016-11-23 | 合肥宝花堂健康咨询有限公司 | 一种外用中药膏 |
Non-Patent Citations (1)
Title |
---|
"紫草膏";弦歌;《https://www.douban.com/note/498704113/》;20150511;1 * |
Also Published As
Publication number | Publication date |
---|---|
CN108567906A (zh) | 2018-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104324338A (zh) | 一种褥疮用护理贴 | |
KR20240102982A (ko) | 두드러기, 습진, 알레르기/변태반응체질 치료를 위한 중약제제 | |
CN108567906B (zh) | 一种紫草膏及其制备方法 | |
CN102247562A (zh) | 一种治疗痤疮的中药配方 | |
CN102526280B (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN104547584A (zh) | 一种促进刨宫产手术后切口愈合的中药喷剂及制备方法 | |
CN104491220B (zh) | 一种治疗带状疱疹的中药组合物 | |
CN104940886A (zh) | 一种治疗脂溢性脱发的外用制剂及制法 | |
CN103845616A (zh) | 一种消炎杀菌的药物组合物 | |
CN103432466B (zh) | 治疗女性盆腔炎的中药组合物及其制备方法 | |
CN114306442A (zh) | 一种治疗特应性皮炎的中药组合物及其应用 | |
CN107823303B (zh) | 一种治疗痔疮的壮医外用熏洗汤 | |
CN100423767C (zh) | 一种治疗烧、烫伤的药物及其制备方法 | |
CN103989771A (zh) | 珍珠粉烫伤膏 | |
CN105148147A (zh) | 治疗创伤或褥疮感染的中药及其制备方法 | |
CN104740106A (zh) | 治疗烫伤的外用药物组合物、治疗烫伤的外用药油及其制作方法 | |
CN104983978A (zh) | 治疗烧伤的外用药物组合物、治疗烧伤的外用药膏及其制作方法 | |
CN105456708B (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN104189190A (zh) | 瘙痒性鹅掌风中药药浴及制备方法 | |
CN103251779B (zh) | 专治猪冻伤的中药药膏 | |
CN108114220A (zh) | 一种治疗鼻炎的胶囊剂药物及制备方法 | |
CN105833074A (zh) | 治疗口腔溃疡的中药组合物 | |
CN103784725A (zh) | 一种治疗产后出血的中草药配方及其制备方法 | |
CN105079337A (zh) | 一种预防褥疮的护理液及其制备方法 | |
CN103977223A (zh) | 一种散寒通窍的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |